Category Archives: Antibody News

04Dec/18

CCR4 Targeted Antibody Drug Poteligeo Approved by EC for Lymphoma

December 4, 2018Antibody Application, Antibody News, Antibody ResearchAntibody Production, Immunotherapy Antibody, Monoclonal antibody, Therapeutic Antibodybio-anti

Kyowa Hakko Kirin, a Japanese pharmaceutical company, recently announced that the European Commission (EC) has approved Poteligeo (mogamulizumab) to treat adult patients with relapsed or refractory mycosis fugoides (MF) or Sezary syndromeRead More…

12Nov/18

A New Generation of Agonist Antibodies for Tumor Immune Checkpoint

November 12, 2018Antibody Application, Antibody News, Antibody ResearchAntibody Discovery, Antibody Research, Immunotherapy Antibody, Therapeutic Antibody, Tumor Antibodybio-anti

In the past decade, tumor immunotherapy has overturned the traditional concept of treatment, especially the discovery and application of immune checkpoint molecules. The immune checkpoint can be irritating or inhibitory, and theRead More…